Silicone Gel Versus Contractubex Gel effect on Scar

Phase 3

• Conditions: Keloid scar.; Hypertrophic scar; L91.0

• Registration Number: IRCT20141218020364N10
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 150

Inclusion Criteria

male gender
aged between 18-45 year
able to read and write informed consent and questionnaire

Exclusion Criteria

mental disorders
peripheral vascular diseases
acute viral diseases
men who developed surgical complications such as wound infection
men who had a history of hypertrophic or keloid scarring in upper extremity
men who were taking chemotherapeutic agents or other medications that would affect wound healing
men who had comorbidities such as contractive skin disorders (e.g., scleroderma)
men who had allergy to silicone or onion

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Height of scar. Timepoint: 4 months after the start of intervention. Method of measurement: With a ruler and scoring based on the Vancouver scar scale.;Vascularity of scar. Timepoint: 4 months after the start of intervention. Method of measurement: Observation and evaluation of post-white fill velocity due to pressure and scoring based on the Vancouver scar scale.;Pliability of scar. Timepoint: 4 months after the start of intervention. Method of measurement: Touch and scoring based on the Vancouver scar scale.;Pigmentation of scar. Timepoint: 4 months after the start of intervention. Method of measurement: view and scoring based on the Vancouver scar scale.